Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Progressive Digital Media Group PLC       GB00B1GCQP32

News SummaryMost relevantAll newsSector newsTweets

GlobalData : Asia-Pacific pedicle screw-based dynamic stabilization systems market to surpass $19 million by 2023

share with twitter share with LinkedIn share with facebook
share via e-mail
07/19/2017 | 12:18pm CEST

The pedicle screw-based dynamic stabilization systems space across the seven major Asia-Pacific (APAC) markets of Australia, China, India, Japan, New Zealand, South Korea and Taiwan, is set to rise from $12.5 million in 2016 to $19.2 million by 2023, representing a compound annual growth rate (CAGR) of 6.3%, according to research and consulting firm GlobalData.

The company's latest report states that key drivers of this growth include the rising prevalence of degenerative spinal conditions due to the increasing aging population and the system's advantages over traditional spinal fusion procedures, including motion preservation.

Jennifer Ryan, Healthcare Analyst for GlobalData, explains: 'Future adoption of pedicle screw-based dynamic stabilization systems is highly dependent on the procurement of clinical efficacy data demonstrating support for device utilization.

'This is because, despite generating great enthusiasm upon their introduction to the market, pedicle screw-based dynamic stabilization systems have attracted concern over the long-term clinical efficacy of these devices, with reports emerging of devices loosening and failing. As such, spinal fusion remains the gold standard treatment for patients with degenerative spinal disorders.'

In terms of key players, the pedicle screw-based dynamic stabilization systems market is fairly consolidated, with the majority of players consisting of well-established orthopedic and spine companies. Zimmer Biomet's Dynesys system is the principal player worldwide, and systems from Globus Medical and Paradigm Spine are also highly utilized.

Ryan continues: 'Lingering questions about the clinical effectiveness of these pedicle screw-based dynamic systems is a major setback threatening the continued adoption of currently marketed devices. GlobalData believes the use of clinical trials focused on efficacy will be an important factor in the future of pedicle-screw based dynamic stabilization systems' adoption and reimbursement.'

In terms of individual countries, China represented the largest portion of the market in 2016, holding just over 40% of the regional revenue, and is expected to maintain this dominance throughout the forecast period. India is expected to be the fastest-growing market through 2023, at a CAGR of 7.9% while the slowest growth will be observed will be observed in New Zealand at a CAGR of 3.7%.

- Information based on GlobalData's report: MediPoint: Pedicle Screw-Based Dynamic Stabilization Systems - APAC Analysis and Market Forecasts.

GlobalData plc published this content on 17 July 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 19 July 2017 10:18:07 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
03:56p GLOBALDATA : Taiwan’s Pharmaceutical Market Value to Reach $2.44 billion i..
03:36p GLOBALDATA : The pet insurance market broke the £1bn mark in gross written premi..
09:46a GLOBALDATA : Affluent market, medical tourism to steer best-in line drug deliver..
10/13 GLOBALDATA : Indonesian Pharmaceutical Market Value to Reach $10.11 billion by 2..
10/12 GLOBALDATA : Faster internet and variety of content to galvanise OTT video marke..
10/11 GLOBALDATA : Crohn’s disease market growth to 2026 fuelled by interleukin ..
10/11 GLOBALDATA : Fintech in good times as investments leap, says GlobalData
10/11 GLOBALDATA : Drug development companies in APAC need to raise their game to capi..
10/10 GLOBALDATA : Alzheimer’s disease market set for double-digit growth with f..
10/08 GLOBALDATA : Huawei Jointly Release Network Experience Index White Paper
More news
Financials ( GBP)
Sales 2017 118 M
EBIT 2017 -
Net income 2017 -
Debt 2017 20,5 M
Yield 2017 1,33%
P/E ratio 2017 -
P/E ratio 2018 -
Capi. / Sales 2017 5,19x
Capi. / Sales 2018 -
Capitalization 593 M
Income Statement Evolution
Michael Thomas Danson Chief Executive Officer
Bernard Anthony Cragg Chairman
Simon John Pyper Chief Financial Officer
Peter Martin Harkness Independent Non-Executive Director
Murray Legg Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
RELX N.V.15.35%45 681
RELX15.94%45 656
S&P GLOBAL INC50.47%41 552
EQUIFAX INC.-7.38%13 070